• Header news

Press Release Investments in Materiomics

Chemelot Ventures BV, Limburg Business Development Fund BV (LBDF) and the current shareholders have decided to jointly invest €1.4 million in Materiomics BV, located at the Brightlands Maastricht Health Campus. This financing round will be used to develop prototypes of medical devices with a smart surface structure like stents, catheters, breast implants, teeth implants and artificial hips. The smart surface structures will be developed in close cooperation with research institute MERLN at Maastricht University, MUMC+ and industrial partners. The entire text of the press release can be found pdfhere.


  • BiS-Biointerface Science in Regenerative Medicine
  • TU/e Department of Biomedical Engineering
Eindhoven University of Technology
PO Box 513
5600 MB, Eindhoven
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cookie & Privacy Statement